The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Rainbow Children's Medicare Ltd

Rainbow Children's Medicare Ltd

BSE 543524 · NSE RAINBOW · ISIN INE961O01016 · Group A · Active

Healthcare › Healthcare › Healthcare Services › Hospital

₹1,438.45

+0.06%

BSE close, 28 August 2026

Market cap

₹14,609.85 cr

10.2 cr shares · Small cap

Free float

₹7,299.32 cr

as published

P/E · P/B

58.2× · 10.68×

EPS ₹24.71 · BV ₹134.69

FY25-26 rev / PAT

1,545.66 / 250.02

₹ cr, as filed

Filings, window

33

13 selected · 39%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹1,008.75 52-WK HIGH ₹1,609.00 ₹1,438.45 72% of range
Against 52-week high-10.6%
Against 52-week low+42.6%
Day change+0.06%
Size bandSmall cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹24.71
Price / earnings58.21×
Price / book10.68×
Book value — derived, price ÷ P/B₹134.69
Return on equity18.36%
Operating margin31.04%
Net margin12.84%

Consistency check

P/B ÷ P/E, which must equal ROE
18.35%
ROE as published
18.36%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 410.55 52.71 5.20 31.04% 12.84%
Mar-26 · Q 408.06 59.31 5.85 32.50% 14.53%
FY25-26 1,545.66 250.02 24.62 35.05% 16.18%

Quarter on quarter

Revenue, quarter on quarter
+0.6%
Net profit, quarter on quarter
-11.1%
Operating margin, quarter on quarter
-146 bps

Disclosure profile 33 filings in the window

0 median 17.0 p75 · 25 sector max 52 33 92th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

33 filings · 13 selected · busiest 2026-07-29

Filing rhythm · the twelve most recent

2026-08-252026-10-07

SelectedProcedural

Filings

33 in the window · 3 earlier on record

  1. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 30 September 2026 ·

    General

    Intimation Of Execution Of Lease Agreement With APCRDA For Development Of A Children'S Hospital At Amravati, Andhra Pradesh.

    Intimation of execution of lease agreement with APCRDA.

    Company Update / General View filing →

  3. 29 September 2026 ·

    Credit Rating

    Credit Rating

    Credit Rating

    Company Update / Credit Rating View filing →

  4. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Initimation for trading window closure for quarter and half year ended September 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 23 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board Meeting for Appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) of the Company and other general matters

    Others / Outcome without intimation View filing →

  6. 23 September 2026 ·

    General

    Intimation Of Contact Details Of Key Managerial Personnel Authorised Under Regulation 30(5) Of SEBI (LODR) Regulations, 2015

    Intimation of contact details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) Regulations, 2015

    Company Update / General View filing →

  7. 23 September 2026 ·

    General

    Intimation For Grant Of Options

    Intimation for grant of options

    Company Update / General View filing →

  8. 23 September 2026 ·

    Change in Management

    Change in Management

    Appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) of the Company

    Company Update / Change in Management View filing →

  9. 16 September 2026 ·

    General

    Announcement Under Regulation 30 - Update On Commencement Of Operations At Guntur, Andhra Pradesh.

    Update on Commencement of Operations at Guntur, Andhra Pradesh.

    Company Update / General View filing →

  10. 11 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/Institutional Investor Group Meetings.

    Company Update / Analyst / Investor Meet View filing →

  11. 31 August 2026 ·

    KMP

    Cessation

    Resignation of Senior Management Personnel.

    Company Update / Cessation View filing →

  12. 25 August 2026 ·

    Change in Management

    Change in Management

    Resignation of Mr. Vikas Maheshwari as Chief Financial Officer of the Company w.e.f. August 31, 2026

    Company Update / Change in Management View filing →

  13. 14 August 2026 ·

    General

    Update On Acquisition

    Update on acquisition

    Company Update / General View filing →

  14. 4 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Earnings Call Transcript for the quarter ended June 30, 2026

    Company Update / Earnings Call Transcript View filing →

  15. 31 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Link of Audio recording of Earnings Conference call for quarter ended June 30, 2026

    Company Update / Analyst / Investor Meet View filing →

  16. 31 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of financial results for quarter ended June 30, 2026

    Company Update / Newspaper Publication View filing →

  17. 30 July 2026 ·

    Press Release

    Press Release / Media Release

    Press release for the quarter ended June 30, 2026

    Company Update / Press Release / Media Release View filing →

  18. 30 July 2026 ·

    Investor Presentation

    Investor Presentation

    Earnings Presentation for the quarter ended June 30, 2026

    Company Update / Investor Presentation View filing →

  19. 30 July 2026 ·

    General

    Intimation Regarding Grant Of Options Under Employee Stock Option Scheme 2025

    Intimation regarding grant of options under Employee Stock Option Scheme 2025

    Company Update / General View filing →

  20. 30 July 2026 ·

    Change in Management

    Change in Management

    Appointment as senior management personnel

    Company Update / Change in Management View filing →

  21. 30 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026

    Un-audited financial results (Standalone & Consolidated) for the quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  22. 30 July 2026 ·

    Results

    Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026

    Un-audited financial results (Standalone & Consolidated) for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  23. 29 July 2026 ·

    General

    Intimation For Capacity Addition

    Intimation for capacity addition

    Company Update / General View filing →

  24. 29 July 2026 ·

    General

    Intimation For Capacity Addition

    Intimation for capacity addition

    Company Update / General View filing →

  25. 29 July 2026 ·

    Acquisition

    Acquisition

    Intimation for acquisition

    Company Update / Acquisition View filing →

  26. 29 July 2026 ·

    Restructuring

    Restructuring

    Sale of stake

    Company Update / Restructuring View filing →

  27. 29 July 2026 ·

    General

    Capacity Addition

    Intimation for capacity addition

    Company Update / General View filing →

  28. 29 July 2026 ·

    Acquisition

    Acquisition

    Announcement under Regulation 30 (LODR) - Acquisition

    Company Update / Acquisition View filing →

  29. 29 July 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer's Report and voting results for the 28th Annual General Meeting for FY 2025-26

    AGM/EGM / AGM View filing →

  30. 29 July 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 28th Annual General Meeting for FY 2025-26

    AGM/EGM / AGM View filing →

  31. 23 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Earnings Conference Call for discussion on financial results declared for quarter ended June 30, 2026

    Company Update / Analyst / Investor Meet View filing →

  32. 23 July 2026 ·

    General

    ESG Rating From CRISIL ESG Rating & Analytics Limited

    The company has received ESG Rating from CRISIL ESG Rating & Analytics Limited, assessed on voluntary basis.

    Company Update / General View filing →

  33. 22 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Declaring Unaudited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2026 And Other Matters

    Rainbow Children's Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the unaudited ....

    Board Meeting / Board Meeting View filing →

RSS feed for Rainbow Children's Medicare Ltd · the 50 most recent filings